Accessibility Menu
 

Why Chemours Stock Soared Today

Chemours concluded an internal review, determining its former CEO, CFO, and company controller violated its code of ethics.

By Steve Symington Mar 7, 2024 at 5:02PM EST

Key Points

  • Chemours concluded an internal review it announced last week.
  • The review found that three executives shifted the timing of payables and receivables to meet free cash flow targets and bolster their incentive compensation.
  • The disclosure doesn't impact previously announced preliminary results.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.